Rudd, P. M., Elliott, T., Cresswell, P., Wilson, I. A. & Dwek, R. A. Glycosylation and the immune system. Science 291, 2370–2376 (2001).
Google Scholar
Flynn, R. A. et al. Small RNAs are modified with N-glycans and displayed on the surface of living cells. Cell 184, 3109–3124.e22 (2021).
Google Scholar
Luis, A. S. & Hansson, G. C. Intestinal mucus and their glycans: a habitat for thriving microbiota. Cell Host Microbe 31, 1087–1100 (2023).
Google Scholar
Inaba, R., Vujakovic, S. & Bergstrom, K. The gut mucus network: a dynamic liaison between microbes and the immune system. Semin. Immunol. 69, 101807 (2023).
Google Scholar
Ohtsubo, K. & Marth, J. D. Glycosylation in cellular mechanisms of health and disease. Cell 126, 855–867 (2006).
Google Scholar
Pinho, S. S. & Reis, C. A. Glycosylation in cancer: mechanisms and clinical implications. Nat. Rev. Cancer 15, 540–555 (2015).
Google Scholar
Verhelst, X. et al. Protein glycosylation as a diagnostic and prognostic marker of chronic inflammatory gastrointestinal and liver diseases. Gastroenterology 158, 95–110 (2020).
Google Scholar
Pinho, S. S. & Rabinovich, G. A. The glycoimmune landscape in health and disease. Semin. Immunol. 78, 101965 (2025).
Google Scholar
Pinho, S. S., Alves, I., Gaifem, J. & Rabinovich, G. A. Immune regulatory networks coordinated by glycans and glycan-binding proteins in autoimmunity and infection. Cell Mol. Immunol. 20, 1101–1113 (2023).
Google Scholar
Vicente, M. M., Leite-Gomes, E. & Pinho, S. S. Glycome dynamics in T and B cell development: basic immunological mechanisms and clinical applications. Trends immunol. 44, 585–597 (2023).
Google Scholar
Crouch, L. I. et al. The role of glycans in health and disease: regulators of the interaction between gut microbiota and host immune system. Semin. Immunol. 73, 101891 (2024).
Google Scholar
Estevinho, M. M. et al. Emerging role of environmental pollutants in inflammatory bowel disease risk, outcomes and underlying mechanisms. Gut (2024).
Google Scholar
Gaifem, J. et al. A unique serum IgG glycosylation signature predicts development of Crohn’s disease and is associated with pathogenic antibodies to mannose glycan. Nat. Immunol. (2024).
Google Scholar
Garber, K. No added sugar: antibody makers find an upside to ‘no fucose’. Nat. Biotechnol. 36, 1025–1027 (2018).
Google Scholar
Kaneko, Y., Nimmerjahn, F. & Ravetch, J. V. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313, 670–673 (2006).
Google Scholar
Huffman, J. E. et al. Comparative performance of four methods for high-throughput glycosylation analysis of immunoglobulin G in genetic and epidemiological research. Mol. Cell. Proteomics 13, 1598–1610 (2014).
Google Scholar
Dressman, J. W. et al. Development of an antibody-based platform for the analysis of immune cell-specific N-linked glycosylation. Anal. Chem. 95, 10289–10297 (2023).
Google Scholar
Marie, A. L., Gao, Y. & Ivanov, A. R. Native N-glycome profiling of single cells and ng-level blood isolates using label-free capillary electrophoresis-mass spectrometry. Nat. Commun. 15, 3847 (2024).
Google Scholar
Hracs, L. et al. Global evolution of inflammatory bowel disease across epidemiologic stages. Nature (2025).
Google Scholar
Kaplan, G. G. The global burden of inflammatory bowel disease: from 2025 to 2045. Nat. Rev. Gastroenterol. Hepatol. 22, 708–720 (2025).
Google Scholar
Torres, J., Ungaro, R. C. & Colombel, J. F. Is prevention the best way to modify inflammatory bowel disease? How close are we? Gastroenterology (2021).
Google Scholar
Torres, J., Burisch, J., Riddle, M., Dubinsky, M. & Colombel, J. F. Preclinical disease and preventive strategies in IBD: perspectives, challenges and opportunities. Gut 65, 1061–1069 (2016).
Google Scholar
Torres, J. et al. Serum biomarkers identify patients who will develop inflammatory bowel diseases up to 5 years before diagnosis. Gastroenterology 159, 96–104 (2020).
Google Scholar
Linden, S. K., Sutton, P., Karlsson, N. G., Korolik, V. & McGuckin, M. A. Mucins in the mucosal barrier to infection. Mucosal Immunol. 1, 183–197 (2008).
Google Scholar
Schneider, H., Pelaseyed, T., Svensson, F. & Johansson, M. E. V. Study of mucin turnover in the small intestine by in vivo labeling. Sci. Rep. 8, 5760 (2018).
Google Scholar
Hansson, G. C. Mucins and the microbiome. Annu. Rev. Biochem. 89, 769–793 (2020).
Google Scholar
Marth, J. D. & Grewal, P. K. Mammalian glycosylation in immunity. Nat. Rev. Immunol. 8, 874–887 (2008).
Google Scholar
Green, R. S. et al. Mammalian N-glycan branching protects against innate immune self-recognition and inflammation in autoimmune disease pathogenesis. Immunity 27, 308–320 (2007).
Google Scholar
Granovsky, M. et al. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat. Med. 6, 306–312 (2000).
Google Scholar
Demetriou, M., Granovsky, M., Quaggin, S. & Dennis, J. W. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409, 733–739 (2001).
Google Scholar
Dias, A. M. et al. Dysregulation of T cell receptor N-glycosylation: a molecular mechanism involved in ulcerative colitis. Hum. Mol. Genet. 23, 2416–2427 (2014).
Google Scholar
Mortales, C. L., Lee, S. U. & Demetriou, M. N-glycan branching is required for development of mature B cells. J. Immunol. 205, 630–636 (2020).
Google Scholar
Zhou, R. W. et al. N-glycosylation bidirectionally extends the boundaries of thymocyte positive selection by decoupling Lck from Ca2+ signaling. Nat. Immunol. 15, 1038–1045 (2014).
Google Scholar
van Kooyk, Y. & Rabinovich, G. A. Protein-glycan interactions in the control of innate and adaptive immune responses. Nat. Immunol. 9, 593–601 (2008).
Google Scholar
Rodrigues, C. S. et al. Alterations in mucosa branched N-glycans lead to dysbiosis and downregulation of ILC3: a key driver of intestinal inflammation. Gut Microbes 17, 2461210 (2025).
Google Scholar
Lau, K. S. et al. Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell 129, 123–134 (2007).
Google Scholar
Chen, H. L., Li, C. F., Grigorian, A., Tian, W. & Demetriou, M. T cell receptor signaling co-regulates multiple Golgi genes to enhance N-glycan branching. J. Biol. Chem. 284, 32454–32461 (2009).
Google Scholar
Morosi, L. G. et al. Control of intestinal inflammation by glycosylation-dependent lectin-driven immunoregulatory circuits. Sci. Adv. 7, eabf8630 (2021).
Google Scholar
Pickard, J. M. et al. Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness. Nature 514, 638–641 (2014).
Google Scholar
Newburg, D. S. & Morelli, L. Human milk and infant intestinal mucosal glycans guide succession of the neonatal intestinal microbiota. Pediatr. Res. 77, 115–120 (2015).
Google Scholar
Briliute, J. et al. Complex N-glycan breakdown by gut Bacteroides involves an extensive enzymatic apparatus encoded by multiple co-regulated genetic loci. Nat. Microbiol. 4, 1571–1581 (2019).
Google Scholar
El Kaoutari, A., Armougom, F., Gordon, J. I., Raoult, D. & Henrissat, B. The abundance and variety of carbohydrate-active enzymes in the human gut microbiota. Nat. Rev. Microbiol. 11, 497–504 (2013).
Google Scholar
Koropatkin, N. M., Cameron, E. A. & Martens, E. C. How glycan metabolism shapes the human gut microbiota. Nat. Rev. Microbiol. 10, 323–335 (2012).
Google Scholar
Holmberg, S. M. et al. The gut commensal Blautia maintains colonic mucus function under low-fiber consumption through secretion of short-chain fatty acids. Nat. Commun. 15, 3502 (2024).
Google Scholar
Khan, M. T. et al. Synergy and oxygen adaptation for development of next-generation probiotics. Nature 620, 381–385 (2023).
Google Scholar
Kappler, K. & Hennet, T. Emergence and significance of carbohydrate-specific antibodies. Genes Immun. 21, 224–239 (2020).
Google Scholar
New, J. S. et al. Neonatal exposure to commensal-bacteria-derived antigens directs polysaccharide-specific B-1 B cell repertoire development. Immunity 53, 172–186.e6 (2020).
Google Scholar
Polonskaya, Z. et al. T cells control the generation of nanomolar-affinity anti-glycan antibodies. J. Clin. Invest. 127, 1491–1504 (2017).
Google Scholar
Polonskaya, Z., Savage, P. B., Finn, M. G. & Teyton, L. High-affinity anti-glycan antibodies: challenges and strategies. Curr. Opin. Immunol. 59, 65–71 (2019).
Google Scholar
Harding, C. V., Kihlberg, J., Elofsson, M., Magnusson, G. & Unanue, E. R. Glycopeptides bind MHC molecules and elicit specific T cell responses. J. Immunol. 151, 2419–2425 (1993).
Google Scholar
Kim, M. & Kim, C. H. Regulation of humoral immunity by gut microbial products. Gut Microbes 8, 392–399 (2017).
Google Scholar
Alves, I., Fernandes, A., Santos-Pereira, B., Azevedo, C. M. & Pinho, S. S. Glycans as a key factor in self and non-self discrimination: impact on the breach of immune tolerance. FEBS Lett. (2022).
Google Scholar
Pereira, M. S. et al. A (glyco)biomarker that predicts failure to standard therapy in ulcerative colitis patients. J. Crohns Colitis (2018).
Google Scholar
Brazil, J. C. & Parkos, C. A. Finding the sweet spot: glycosylation mediated regulation of intestinal inflammation. Mucosal Immunol. 15, 211–222 (2022).
Google Scholar
Probert, C. S. et al. South Asian and European colitics show characteristic differences in colonic mucus glycoprotein type and turnover. Gut 36, 696–702 (1995).
Google Scholar
Pereira, M. S. et al. Genetic variants of the MGAT5 gene are functionally implicated in the modulation of T cells glycosylation and plasma IgG glycome composition in ulcerative colitis. Clin. Transl. Gastroenterol. 11, e00166 (2020).
Google Scholar
Dias, A. M. et al. Metabolic control of T cell immune response through glycans in inflammatory bowel disease. Proc. Natl Acad. Sci. 115, E4651–E4660 (2018).
Google Scholar
Vicente, M. M. et al. Mannosylated glycans impair normal T-cell development by reprogramming commitment and repertoire diversity. Cell Mol. Immunol. 20, 955–968 (2023).
Google Scholar
Fujii, H. et al. Core fucosylation on T cells, required for activation of T-cell receptor signaling and induction of colitis in mice, is increased in patients with inflammatory bowel disease. Gastroenterology 150, 1620–1632 (2016).
Google Scholar
McGovern, D. P. et al. Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn’s disease. Hum. Mol. Genet. 19, 3468–3476 (2010).
Google Scholar
Brown, S. J. et al. Altered immune system glycosylation causes colitis in α1,2-fucosyltransferase transgenic mice. Inflamm. Bowel Dis. 10, 546–556 (2004).
Google Scholar
Goto, Y. et al. Innate lymphoid cells regulate intestinal epithelial cell glycosylation. Science 345, 1254009 (2014).
Google Scholar
Yao, Y. et al. Mucus sialylation determines intestinal host-commensal homeostasis. Cell 185, 1172–1188.e1128 (2022).
Google Scholar
Kelm, M. et al. Targeting epithelium-expressed sialyl Lewis glycans improves colonic mucosal wound healing and protects against colitis. JCI Insight 5, e135843 (2020).
Google Scholar
Parikh, K. et al. Colonic epithelial cell diversity in health and inflammatory bowel disease. Nature 567, 49–55 (2019).
Google Scholar
Nystrom, E. E. L. et al. An intercrypt subpopulation of goblet cells is essential for colonic mucus barrier function. Science 372, eabb1590 (2021).
Google Scholar
An, G. et al. Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans. J. Exp. Med. 204, 1417–1429 (2007).
Google Scholar
Fu, J. et al. Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice. J. Clin. Invest. 121, 1657–1666 (2011).
Google Scholar
Bergstrom, K. et al. Core 1- and 3-derived O-glycans collectively maintain the colonic mucus barrier and protect against spontaneous colitis in mice. Mucosal Immunol. 10, 91–103 (2017).
Google Scholar
Bergstrom, K. et al. Defective intestinal mucin-type O-glycosylation causes spontaneous colitis-associated cancer in mice. Gastroenterology 151, 152–164.e11 (2016).
Google Scholar
Larsson, J. M. et al. Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation. Inflamm. Bowel Dis. 17, 2299–2307 (2011).
Google Scholar
Kudelka, M. R. et al. Cosmc is an X-linked inflammatory bowel disease risk gene that spatially regulates gut microbiota and contributes to sex-specific risk. Proc. Natl Acad. Sci. 113, 14787–14792 (2016).
Google Scholar
Roy, A. et al. N-glycosylation enzyme Mpi is essential for mucin O-glycosylation, host-microbe homeostasis, Paneth cell defense, and metabolism. Preprint at Res. Sq. (2025).
Dotan, I. et al. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn’s disease. Gastroenterology 131, 366–378 (2006).
Google Scholar
Sendid, B. et al. Specific antibody response to oligomannosidic epitopes in Crohn’s disease. Clin. Diagn. Lab. Immunol. 3, 219–226 (1996).
Google Scholar
Sendid, B. et al. From ASCA breakthrough in Crohn’s disease and Candida albicans research to thirty years of investigations about their meaning in human health. Autoimmun. Rev. 23, 103486 (2024).
Google Scholar
Morishima, N. et al. Generation and validation of antibody 42B1 recognizing galactose-deficient IgG for diagnosis of chronic inflammatory diseases. Clin. Chim. Acta 566, 120052 (2025).
Google Scholar
Trbojevic Akmacic, I. et al. Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome. Inflamm. Bowel Dis. 21, 1237–1247 (2015).
Google Scholar
Kaul, A. et al. Serum anti-glycan antibody biomarkers for inflammatory bowel disease diagnosis and progression: a systematic review and meta-analysis. Inflamm. Bowel Dis. 18, 1872–1884 (2012).
Google Scholar
Bourgonje, A. R. et al. Phage-display immunoprecipitation sequencing of the antibody epitope repertoire in inflammatory bowel disease reveals distinct antibody signatures. Immunity 56, 1393–1409.e6 (2023).
Google Scholar
Alves, I. et al. Protein mannosylation as a diagnostic and prognostic biomarker of lupus nephritis: an unusual glycan-neoepitope in systemic lupus erythematosus. Arthritis Rheumatol. (2021).
Google Scholar
Alves, I. et al. Host-derived mannose glycans trigger a pathogenic γδ T cell/IL-17a axis in autoimmunity. Sci. Transl. Med. 15, eabo1930 (2023).
Google Scholar
Fekete, E. & Buret, A. G. The role of mucin O-glycans in microbiota dysbiosis, intestinal homeostasis, and host-pathogen interactions. Am. J. Physiol. Gastrointest. Liver Physiol. 324, G452–G465 (2023).
Google Scholar
Akdis, C. A. Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions? Nat. Rev. Immunol. 21, 739–751 (2021).
Google Scholar
Monteleone, G., Moscardelli, A., Colella, A., Marafini, I. & Salvatori, S. Immune-mediated inflammatory diseases: common and different pathogenic and clinical features. Autoimmun. Rev. 22, 103410 (2023).
Google Scholar
van der Post, S. et al. Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis. Gut 68, 2142–2151 (2019).
Google Scholar
Turpin, W. et al. Increased intestinal permeability is associated with later development of Crohn’s disease. Gastroenterology 159, 2092–2100.e5 (2020).
Google Scholar
Oosterhoff, J. J., Larsen, M. D., van der Schoot, C. E. & Vidarsson, G. Afucosylated IgG responses in humans — structural clues to the regulation of humoral immunity. Trends Immunol. 43, 800–814 (2022).
Google Scholar
Lee, S. H. et al. Anti-microbial antibody response is associated with future onset of Crohn’s disease independent of biomarkers of altered gut barrier function, subclinical inflammation, and genetic risk. Gastroenterology 161, 1540–1551 (2021).
Google Scholar
Mortha, A. et al. Neutralizing anti-granulocyte macrophage-colony stimulating factor autoantibodies recognize post-translational glycosylations on granulocyte macrophage-colony stimulating factor years before diagnosis and predict complicated Crohn’s disease. Gastroenterology 163, 659–670 (2022).
Google Scholar
Dias, A. M. et al. Glycans as critical regulators of gut immunity in homeostasis and disease. Cell Immunol. (2018).
Google Scholar
Huffman, J. E. et al. Polymorphisms in B3GAT1, SLC9A9 and MGAT5 are associated with variation within the human plasma N-glycome of 3533 European adults. Hum. Mol. Genet. 20, 5000–5011 (2011).
Google Scholar
Klaric, L. et al. Glycosylation of immunoglobulin G is regulated by a large network of genes pleiotropic with inflammatory diseases. Sci. Adv. 6, eaax0301 (2020).
Google Scholar
Simurina, M. et al. Glycosylation of immunoglobulin G associates with clinical features of inflammatory bowel diseases. Gastroenterology 154, 1320–1333.e10 (2018).
Google Scholar
Choi, E. K. et al. The manganese transporter SLC39A8 links alkaline ceramidase 1 to inflammatory bowel disease. Nat. Commun. 15, 4775 (2024).
Google Scholar
Moller, F. T., Andersen, V., Wohlfahrt, J. & Jess, T. Familial risk of inflammatory bowel disease: a population-based cohort study 1977-2011. Am. J. Gastroenterol. 110, 564–571 (2015).
Google Scholar
Martens, E. C., Neumann, M. & Desai, M. S. Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier. Nat. Rev. Microbiol. 16, 457–470 (2018).
Google Scholar
Wu, G. D. et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334, 105–108 (2011).
Google Scholar
Ananthakrishnan, A. N., Whelan, K., Allegretti, J. R. & Sokol, H. Diet and microbiome-directed therapy 2.0 for IBD. Clin. Gastroenterol. Hepatol. 23, 406–418 (2025).
Google Scholar
Agrawal, M. et al. Per- and poly-fluoroalkyl substances exposure is associated with later occurrence of inflammatory bowel disease. Clin. Gastroenterol. Hepatol. 22, 1728–1730.e8 (2024).
Google Scholar
Liu, J. et al. Associations between the serum levels of PFOS/PFOA and IgG N-glycosylation in adult or children. Env. Pollut. 265, 114285 (2020).
Google Scholar
Irving, P. M. & Gibson, P. R. Infections and IBD. Nat. Clin. Pract. Gastroenterol. Hepatol. 5, 18–27 (2008).
Google Scholar
Craviotto, V. et al. Viral infections in inflammatory bowel disease: tips and tricks for correct management. World J. Gastroenterol. 27, 4276–4297 (2021).
Google Scholar
Nandy, A. et al. Epstein–Barr virus exposure precedes Crohn’s disease development. Gastroenterology (2025).
Google Scholar
Aspinall, G. O. et al. Lipopolysaccharides from Campylobacter jejuni associated with Guillain–Barré syndrome patients mimic human gangliosides in structure. Infect. Immun. 62, 2122–2125 (1994).
Google Scholar
Lee, S. H., Lopes, E., Colombel, J. F. & Ungaro, R. Identifying potential targets for the interception of inflammatory bowel disease: toward precision prevention. Inflamm. Bowel Dis. (2025).
Google Scholar
Leite-Gomes, E. et al. T-cell branched glycosylation as a mediator of colitis-associated colorectal cancer progression: a potential new risk biomarker in inflammatory bowel disease. J. Crohns Colitis 19, jjaf043 (2025).
Google Scholar
Clerc, F. et al. Plasma N-glycan signatures are associated with features of inflammatory bowel diseases. Gastroenterology 155, 829–843 (2018).
Google Scholar
Shubhakar, A. et al. Serum N-glycomic biomarkers predict treatment escalation in inflammatory bowel disease. J. Crohns Colitis 17, 919–932 (2023).
Google Scholar
Bergstrom, K. et al. Proximal colon-derived O-glycosylated mucus encapsulates and modulates the microbiota. Science 370, 467–472 (2020).
Google Scholar
Fancy, N. et al. Fecal-adherent mucus is a non-invasive source of primary human MUC2 for structural and functional characterization in health and disease. J. Biol. Chem. 300, 105675 (2024).
Google Scholar
Masselot, C. R. et al. Fecal mucin O-glycans as novel biomarkers in inflammatory bowel diseases. Inflamm. Bowel Dis. 29, e12 (2023).
Google Scholar
van Tol, B. D. M. et al. Comprehensive immunoglobulin G, A, and M glycopeptide profiling for large-scale biomedical research. Mol. Cell. Proteomics 24, 100928 (2025).
Google Scholar
Levin, R. M., Krieger, N. N. & Winzler, R. J. Glucmsumine and acetylglucosamine tolerance in man. J. Lab. Clin. Med. 58, 927–932 (1961).
Google Scholar
Salvatore, S. et al. A pilot study of N-acetyl glucosamine, a nutritional substrate for glycosaminoglycan synthesis, in paediatric chronic inflammatory bowel disease. Aliment. Pharmacol. Ther. 14, 1567–1579 (2000).
Google Scholar
Schalich, K. M. et al. A human milk oligosaccharide prevents intestinal inflammation in adulthood via modulating gut microbial metabolism. mBio 15, e0029824 (2024).
Google Scholar
link